Impact of health technology assessment on prescribing patterns of inhaled fixed-dose combination triple therapy in chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Impact of health technology assessment on prescribing patterns of inhaled fixed-dose combination triple therapy in chronic obstructive pulmonary disease

Published:2021-01-01 Issue:1 Volume:9 Page:
ISSN:2001-6689
Container-title:Journal of Market Access & Health Policy
language:en
Short-container-title:Journal of Market Access & Health Policy

Author:

Cook Jennifer¹,Bloom Chloe²,Lewis Jen³,Marjenberg Zoe³,Platz Jaime Hernando¹,Langham Sue³

Affiliation:

1. TA Cardio Metabolism Respiratory Global Market Access, Boehringer Ingelheim GmbH, Ingelheim Am Rhein, Germany

2. Faculty of Medicine, National Heart & Lung Institute, Imperial College London, London

3. Maverex Limited, Manchester, UK

Funder

Boehringer Ingelheim

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/20016689.2021.1929757

Reference23 articles.

1. GOLD. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [Internet]. 2020 [cited 2020 Apr 16]. Available from: https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf

2. Dual LABA/LAMA Therapy versus LABA or LAMA Monotherapy for Chronic Obstructive Pulmonary Disease. A Systematic Review and Meta-analysis in Support of the American Thoracic Society Clinical Practice Guideline

Changes in COPD inhaler prescriptions in the United Kingdom, 2000 to 2016

4. Treatment patterns in COPD patients newly diagnosed in primary care. A population-based study

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modification of Apremilast from Pills to Aerosol a Future Concept;International Journal of Environmental Research and Public Health;2021-11-04